Stay updated on Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial page.

Latest updates to the Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial page
- Check6 days agoChange DetectedThe footer’s ClinicalTrials.gov software revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check12 days agoChange DetectedA sitewide notice announces the NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.4%

- Check19 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check26 days agoChange DetectedThe ClinicalTrials.gov site revision in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision tag v3.7.0 was added to the page history, indicating the latest update to the record. The prior revision v3.6.6 was removed from the current history view.SummaryDifference0.1%

- Check68 days agoChange DetectedThe history shows a new revision tag v3.6.6 replacing the previous v3.6.5. This indicates a system or UI update to the study record history page rather than a modification of the trial data.SummaryDifference0.1%

Stay in the know with updates to Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial page.